{"schema_version":"secwatch.filing_event.v1","accession":"0001867096-25-000031","form_type":"8-K","ticker":"XERS","cik":"0001867096","company_name":"Xeris Biopharma Holdings, Inc.","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.384859+00:00","generated_at":"2026-05-26T06:25:49.941532+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Xeris appoints Dr. Anh Nguyen as CMO; Ken Johnson retiring April 1, 2025","bullets":["Dr. Anh Nguyen named Chief Medical Officer effective Feb 24, 2025.","Ken Johnson, SVP Global Dev & Medical Affairs, to retire April 1, 2025.","Nguyen will lead Medical, Regulatory, Preclinical/Clinical Dev, Pharmacovigilance.","Nguyen previously served as program medical lead for Gvoke NDA/MAA at Xeris."],"urls":{"canonical":"https://secwatch.observer/filing/0001867096-25-000031","json":"https://secwatch.observer/filing/0001867096-25-000031.json","markdown":"https://secwatch.observer/filing/0001867096-25-000031.md","text":"https://secwatch.observer/filing/0001867096-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867096/000186709625000031/0001867096-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867096/000186709625000031/xers-20250224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:25:49.941532+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70289de9db","claim":"Ken Johnson retired as Senior Vice President, Global Development and Medical Affairs at Xeris Biopharma Holdings, Inc..","evidence_excerpt":"On February 24, 2025, Mr. Ken Johnson, Pharm.D. notified Xeris Biopharma Holdings, Inc. (the “Company”) of his decision to retire as Senior Vice President, Global Development and Medical Affairs, effective as of April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1867096/000186709625000031/0001867096-25-000031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Senior Vice President, Global Development and Medical Affairs"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}